HealthcareLisata jumps on FDA orphan drug status for liver cancer drugBy Helitra.com·September 7, 2024·1 min read Lisata jumps on FDA orphan drug status for liver cancer drug Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer drug FDA jumps Lisata liver orphan status Post navigation Previous storyAscendis raised to outperform by Oppenheimer ahead of drug launchNext storyEli Lilly bets $409M for AI-focused drug discovery
Fitness · Healthcare2027 Could Be the Year Hair Loss Treatment Finally ChangesNovember 10, 2026As part of the Future of Beauty Awards, the ELLE beauty team looked ahead at what will be next in beauty and wellness.…
Fitness · HealthcareCan Acne Be Prevented With a Vaccine? Inside the Race to Cure Acne.November 10, 2026“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” Treating adult acne can feel like one big…
Fitness · HealthcareMuscle Memory: Why Regaining Lost Muscle Is Easier Than Building It InitiallyNovember 10, 2026Why Your Body Remembers Muscle You’ve Already Built Taking time away from resistance training can lead to noticeable changes in strength, muscle size,…